A Safety, Tolerability, Pharmacokinetic, Food Effect, and Proof-of-Concept Study of Single and Multiple Doses of ORX489 in Healthy Adults
Centessa Pharmaceuticals (UK) Limited
Summary
Characterize the safety, tolerability and pharmacokinetics of ORX489 following single and multiple doses.
Eligibility
- Age range
- 18–60 years
- Sex
- All
- Healthy volunteers
- Yes
Inclusion Criteria: * Healthy males or females as determined by assessments at the Screening Visit. * For Parts A, B, C, and D: Participants must be at least 18 years of age and no more than 60 years of age at the Screening Exclusion Criteria: * Presence of significant cardiac, pulmonary, gastrointestinal, hepatic, renal, hematological, malignancy, endocrine, neurological, or psychiatric disease, as determined by medical history, physical examination, and screening investigations. * History of seizure disorder, any other condition that increases the risk of seizure * Has a clinically signif…
Interventions
- DrugORX489 Tablets
ORX489 Tablets
- OtherPlacebo Tablets
Placebo Tablets
Location
- CelerionLincoln, Nebraska